Mithra and Searchlight Pharma Announce Availability of Nextstellis® in Pharmacies Across Canada

LIEGE (Belgium - 7:30 AM CEST) and MONTREAL (Canada - 7:00 AM EST), September 15, 2021 - Mithra and Searchlight Pharma are pleased to announce that women across Canada looking for the latest advancement in combined oral contraception (COC) now have access to Nextstellis® , a first-of-its-kind COC that includes the unique natural estrogen estetrol (E4), featuring strong efficacy, safety and tolerability with excellent cycle control. E4 is the first new estrogen in a COC in the Canadian market in more than half a century. E4 is naturally produced in the human body during pregnancy and, in Nextstellis, it is synthesized from plant sources.

ant-based sources.

Public link

Please use the above public link if you want to share this noodl on another website.